Cargando…

Clinical significance of tumor necrosis and viability in non-small cell lung cancer

BACKGROUND: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. METHODS: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Seok Whan, Kim, Jae Jun, Jeong, Seong Cheol, Kim, Yong Hwan, Han, Jung Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096282/
https://www.ncbi.nlm.nih.gov/pubmed/35572900
http://dx.doi.org/10.21037/jtd-21-1597
_version_ 1784705940784676864
author Moon, Seok Whan
Kim, Jae Jun
Jeong, Seong Cheol
Kim, Yong Hwan
Han, Jung Wook
author_facet Moon, Seok Whan
Kim, Jae Jun
Jeong, Seong Cheol
Kim, Yong Hwan
Han, Jung Wook
author_sort Moon, Seok Whan
collection PubMed
description BACKGROUND: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. METHODS: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal lymph node dissection for NSCLC between 2015 to 2016, were reviewed retrospectively. We analyzed the associations of TN and TV with various parameters associated with prognosis as well as survival in NSCLC patients. All analyses were performed regarding neoadjuvant therapy status [the group without neoadjuvant therapy (WON) vs. the group with neoadjuvant therapy (WN)]. RESULTS: A consecutive 154 patients (mean age: 65.0±10.1 years) were included into the present study. Fifteen patients underwent neoadjuvant therapy. Final pathologic stages were IA1 (n=13), IA2 (n=30), IA3 (n=32), IB (n=40), IIA (n=9), IIB (n=18), and IIIA (n=12). WN significantly showed higher TN (P=0.005) and lower TV (P<0.001) than WON. Tumors with vascular, lymphatic, and perineural invasion showed significantly lower TV and higher TN than cases without these features (P=0.014, P=0.019, and P=0.012 for TV; P=0.001, P<0.001, and P<0.001 for TN, respectively). Tumors with poorer differentiation had lower TV (P<0.001) and higher TN (P<0.001) than more differentiated tumors. There was a positive correlation between TN and tumor size (P<0.001) and a negative correlation between TV and tumor size (P=0.031). TN significantly increased as pathologic stage increased (P=0.001), and TV significantly decreased as pathologic stage increased (P=0.038). The group without TN survived significantly longer than the group with TN (P=0.016) in N0 disease and presence of TN and pT stage were independent prognostic factors for survival in N0 disease (P=0.037 and P=0.021, respectively). There was a positive correlation between TN and Ki-67 level (P=0.027). In WN, TN was significantly associated with differentiation (P=0.035), tumor size (P=0.008), and pT stage (P=0.031) but not overall pathologic stage or survival. CONCLUSIONS: Presence of histological TN was associated with prognosis of NSCLC, especially in N0 disease, and its usage as a diagnostic or prognostic tool and determination of resection extent could potentially provide prognostic information that can facilitate better management of NSCLC.
format Online
Article
Text
id pubmed-9096282
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-90962822022-05-13 Clinical significance of tumor necrosis and viability in non-small cell lung cancer Moon, Seok Whan Kim, Jae Jun Jeong, Seong Cheol Kim, Yong Hwan Han, Jung Wook J Thorac Dis Original Article BACKGROUND: We included tumor necrosis (TN) and tumor viability (TV) in our prognostic assessment of patients with non-small cell lung cancer (NSCLC) and investigated their clinical significance. METHODS: Medical records of all consecutive subjects who underwent a lobectomy with standard mediastinal lymph node dissection for NSCLC between 2015 to 2016, were reviewed retrospectively. We analyzed the associations of TN and TV with various parameters associated with prognosis as well as survival in NSCLC patients. All analyses were performed regarding neoadjuvant therapy status [the group without neoadjuvant therapy (WON) vs. the group with neoadjuvant therapy (WN)]. RESULTS: A consecutive 154 patients (mean age: 65.0±10.1 years) were included into the present study. Fifteen patients underwent neoadjuvant therapy. Final pathologic stages were IA1 (n=13), IA2 (n=30), IA3 (n=32), IB (n=40), IIA (n=9), IIB (n=18), and IIIA (n=12). WN significantly showed higher TN (P=0.005) and lower TV (P<0.001) than WON. Tumors with vascular, lymphatic, and perineural invasion showed significantly lower TV and higher TN than cases without these features (P=0.014, P=0.019, and P=0.012 for TV; P=0.001, P<0.001, and P<0.001 for TN, respectively). Tumors with poorer differentiation had lower TV (P<0.001) and higher TN (P<0.001) than more differentiated tumors. There was a positive correlation between TN and tumor size (P<0.001) and a negative correlation between TV and tumor size (P=0.031). TN significantly increased as pathologic stage increased (P=0.001), and TV significantly decreased as pathologic stage increased (P=0.038). The group without TN survived significantly longer than the group with TN (P=0.016) in N0 disease and presence of TN and pT stage were independent prognostic factors for survival in N0 disease (P=0.037 and P=0.021, respectively). There was a positive correlation between TN and Ki-67 level (P=0.027). In WN, TN was significantly associated with differentiation (P=0.035), tumor size (P=0.008), and pT stage (P=0.031) but not overall pathologic stage or survival. CONCLUSIONS: Presence of histological TN was associated with prognosis of NSCLC, especially in N0 disease, and its usage as a diagnostic or prognostic tool and determination of resection extent could potentially provide prognostic information that can facilitate better management of NSCLC. AME Publishing Company 2022-04 /pmc/articles/PMC9096282/ /pubmed/35572900 http://dx.doi.org/10.21037/jtd-21-1597 Text en 2022 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Moon, Seok Whan
Kim, Jae Jun
Jeong, Seong Cheol
Kim, Yong Hwan
Han, Jung Wook
Clinical significance of tumor necrosis and viability in non-small cell lung cancer
title Clinical significance of tumor necrosis and viability in non-small cell lung cancer
title_full Clinical significance of tumor necrosis and viability in non-small cell lung cancer
title_fullStr Clinical significance of tumor necrosis and viability in non-small cell lung cancer
title_full_unstemmed Clinical significance of tumor necrosis and viability in non-small cell lung cancer
title_short Clinical significance of tumor necrosis and viability in non-small cell lung cancer
title_sort clinical significance of tumor necrosis and viability in non-small cell lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096282/
https://www.ncbi.nlm.nih.gov/pubmed/35572900
http://dx.doi.org/10.21037/jtd-21-1597
work_keys_str_mv AT moonseokwhan clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer
AT kimjaejun clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer
AT jeongseongcheol clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer
AT kimyonghwan clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer
AT hanjungwook clinicalsignificanceoftumornecrosisandviabilityinnonsmallcelllungcancer